Christopher James Frankenfield

Chief Financial Officer at Xilio Therapeutics · 2 reported transactions in 1 company · latest trade Jan 2, 2026

Their trades


Xilio TherapeuticsXLO	Sold $4.5K · 7,030 shares	Jan 2, 2026	S&P 500 +10.6%thru Oct 30

Jan 2, 2026 · XLO

$4.5K

S&P 500 +10.6%thru Oct 30

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Financial Officer at Xilio Therapeutics · 2 reported transactions in 1 company · latest trade Jan 2, 2026


Xilio TherapeuticsXLO	Sold $4.5K · 7,030 shares	Jan 2, 2026	S&P 500 +10.6%thru Oct 30

Jan 2, 2026 · XLO

$4.5K

S&P 500 +10.6%thru Oct 30

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.